EudraCT Number: 2004-004700-20 Sponsor Protocol Number: 2104-02 Start Date: 2005-03-11
Sponsor Name: Epix Pharmaceuticals, Inc.
Full Title: Phase II Feasibility study of safety and efficacy of Magnetic Resonance Imaging of Thrombi with EP-2104R in the detection in Venous Thromboembolism (VTE)
Medical condition: Detection of venous thromboembolism
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed)
Trial results: (No results available)

EudraCT Number: 2004-004701-23 Sponsor Protocol Number: 2104-03 Start Date: 2005-03-14
Sponsor Name: Epix Pharmaceuticals, Inc.
Full Title: Phase II feasibility study to evaluate the safety and efficacy of EP-2104R for Magnetic Resonance Imaging of thrombi in the arterial vasculature and cardiac chambers
Medical condition: Detection of thrombi in the arterial vasculature and cardiac chambers
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed) DE (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004707-38 Sponsor Protocol Number: CCR 3065 Start Date: 2005-04-08
Sponsor Name: Royal Marsden NHS Trust
Full Title: A multicentre randomised phase II clinical trial comparing oxaliplatin (Eloxatin), capecitabine (Xeloda) and pre-operative radiotherapy with or without cetuximab followed by total mesorectal excisi...
Medical condition: High risk operable rectal adenocarcinoma
Disease: Version SOC Term Classification Code Term Level
13.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10038038 Rectal cancer PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) ES (Ongoing) SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-004710-16 Sponsor Protocol Number: TPU-S1301 Start Date: 2005-07-01
Sponsor Name: Taiho Pharma USA, Inc.
Full Title: An open label, multicenter, randomized, phase 3 study of S-1 in combination with cisplatin compared against 5-FU in combination with cisplatin in patients with advanced gastric cancer previously un...
Medical condition: Advanced gastric cancer
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) HU (Completed) CZ (Completed) DE (Completed) EE (Completed) BE (Completed) ES (Completed) IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004719-43 Sponsor Protocol Number: Start Date: 2005-06-30
Sponsor Name: University of Cambridge
Full Title: The Effects of 6-Month Administration of a Low Growth Hormone Dose on Insulin Sensitivity, Postload Glucose Tolerance and Cardiovascular Disease Risk Markers in Subjects with Impaired Glucose Toler...
Medical condition: Impaired Glucose Tolerance
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: View results

EudraCT Number: 2005-004082-42 Sponsor Protocol Number: OXY-2 Start Date: 2005-12-05
Sponsor Name: Søren Sindrup, Dept. of Neurology, University Hospital of Odense
Full Title: The Pharmacogenetics of Oxycodone analgesia in human experimental pain models
Medical condition: Healthy volunteers
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DK (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-001660-31 Sponsor Protocol Number: 2586 Start Date: 2005-08-05
Sponsor Name: The Royal Marsden Hospital NHS Foundation Trust
Full Title: A Prospective Randomized Controlled Trial of Morphine versus Oxycodone for Cancer Pain: Genetic Determinants of Response to Opioids.
Medical condition: 10-30% of cancer patients have an unsuccessful outcome when given oral morphine because of intolerable side effects. Oxycodone is an alternative opioid which is commonly used as a second line opioi...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2005-001690-99 Sponsor Protocol Number: M6G 022 Start Date: 2005-09-12
Sponsor Name: CeNeS Ltd
Full Title: A RANDOMISED, DOUBLE BLIND STUDY TO COMPARE THE ANALGESIC EFFICACY AND SAFETY PROFILES OF MORPHINE-6-GLUCURONIDE AND MORPHINE SULPHATE, GIVEN AS A LOADING DOSE FOLLOWED BY PATIENT-CONTROLLED ANALGE...
Medical condition: Moderate to Severe Acute Post Operative Pain
Disease: Version SOC Term Classification Code Term Level
10036286
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) ES (Ongoing) DE (Completed) CZ (Completed) HU (Completed)
Trial results: (No results available)
EudraCT Number: 2005-001700-39 Sponsor Protocol Number: IP-REM-PK-01-EU Start Date: 2005-09-14
Sponsor Name: Fresenius Biotech GmbH
Full Title: Determination of systemic exposure and characterization of pharmacokinetics of the tri-functional antibody catumaxomab (anti-EpCAM X anti-CD3) administered intraperitoneally in EpCAM positive cance...
Medical condition: epithelial cell adhesion molecule (EpCAM) expressing tumors in patients with malignant ascites requiring therapeutic ascites puncture
Disease: Version SOC Term Classification Code Term Level
9.1 10025538 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

EudraCT Number: 2006-001472-20 Sponsor Protocol Number: LEO19123-C21 Start Date: 2006-08-15
Sponsor Name: LEO Pharma A/S
Full Title: LEO19123 Cream in the Treatment of Atopic Dermatitis A Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatm...
Medical condition: Atopic dermatitis
Disease: Version SOC Term Classification Code Term Level
8.1 10003639 Atopic dermatitis LLT
Population Age: Adults Gender: Male
Trial protocol: DK (Completed) FI (Completed) GB (Completed)
Trial results: View results